McGill Study Finds Lasting Gene Changes in Ex-Smokers' Lungs After 100,000-Cell Analysis
Updated
Updated · Newsweek · Jul 23
McGill Study Finds Lasting Gene Changes in Ex-Smokers' Lungs After 100,000-Cell Analysis
1 articles · Updated · Newsweek · Jul 23
Summary
More than 100,000 lung cells analyzed by a McGill team showed ex-smokers retain persistent molecular changes even after quitting, helping explain why their disease risk stays above that of people who never smoked.
The meta-analysis covered 21 people—nine never-smokers, seven former smokers and five current smokers—and tracked activity across more than 40 lung cell types.
Some cells appeared to recover after smoking cessation, but others kept altered genes tied to tissue structure, immune function and blood-vessel health.
Former smokers also showed distinct molecular patterns absent in both current smokers and never-smokers, suggesting quitting leaves its own biological signature in the lung.
The findings, published in Translational Research, point researchers toward why some lung damage may be permanent and how future treatments might better restore lung healing.
Since quitting leaves a permanent mark, are e-cigarettes making the lungs of ex-smokers even more vulnerable?
If quitting smoking isn't a full reset, can new therapies truly erase the lung's permanent genetic signature?
The Lasting Epigenetic Impact of Smoking: Insights from the 2026 McGill Study and Future Directions for Ex-Smokers
Overview
Groundbreaking research from McGill University, published in 2026, reveals how quitting smoking leaves a lasting molecular signature in the lungs. Supported by major Canadian research councils, the study used advanced meta-analysis to examine over 100,000 lung cells from people who never smoked, ex-smokers, and current smokers. By comparing these groups, researchers identified subtle but persistent gene changes linked to smoking and its cessation. This detailed approach highlights why ex-smokers may still face health risks long after quitting, offering new insights for future research and targeted health strategies.